Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
J

JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235

Watchlist Manager
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Watchlist
Price: 26.92 CNY 0.07% Market Closed
Market Cap: ¥11.8B
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one JiangXi Tianxin Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 26.92 CNY, JiangXi Tianxin Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JiangXi Tianxin Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

Competitors Multiples
JiangXi Tianxin Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
11.8B CNY 5.3 19.1 17.9 17.9
US
GE Vernova LLC
NYSE:GEV
209B USD 0 0 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
104.1B ZAR 6.2 9.7 15.4 15.4
CH
Galderma Group AG
SIX:GALD
34.4B CHF 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
43.4B USD 0 0 0 0
US
Symbotic Inc
NASDAQ:SYM
35.5B USD 15.8 -2 092.9 -1 040.3 -471.9
US
Coupang Inc
F:788
26.5B EUR 0.9 80.1 20.4 33.5
ZA
Vukile Property Fund Ltd
JSE:VKE
30.8B ZAR 5.8 7.1 17.9 17.9
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
510.5T IDR 42.7 -117.8 2 528 2 528
P/E Multiple
Earnings Growth PEG
CN
J
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Average P/E: 827.4
19.1
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
9.7
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 092.9 N/A N/A
US
Coupang Inc
F:788
80.1
114%
0.7
ZA
V
Vukile Property Fund Ltd
JSE:VKE
7.1
-5%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
Negative Multiple: -117.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
J
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Average EV/EBITDA: 1 002.8
17.9
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
70%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
15.4
9%
1.7
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 040.3 N/A N/A
US
Coupang Inc
F:788
20.4
56%
0.4
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17.9
12%
1.5
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 528
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
J
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Average EV/EBIT: 1 025
17.9
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
91%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
15.4
8%
1.9
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -471.9 N/A N/A
US
Coupang Inc
F:788
33.5
74%
0.5
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17.9
10%
1.8
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 528
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.